• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过与野生型小鼠联体观察 HBs 转基因小鼠的 HBV 免疫耐受。

HBV immune tolerance of HBs-transgenic mice observed through parabiosis with WT mice.

机构信息

Hefei National Laboratory for Physical Sciences at Microscale, the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

Institute of Immunology, University of Science and Technology of China, Hefei, China.

出版信息

Front Immunol. 2022 Sep 20;13:993246. doi: 10.3389/fimmu.2022.993246. eCollection 2022.

DOI:10.3389/fimmu.2022.993246
PMID:36203595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9530942/
Abstract

It was extensively recognized that central tolerance to HBV exists in HBs-transgenic (Tg) mice, however, the immune response to HBV vaccine may be inspired in adult HBs-Tg mice after boosting with potent adjuvants, leaving a mystery to explore its immune tolerance. Here, WT-HBs-Tg parabiotic mice model was generated by conjoining WT (donor) and HBs-Tg (host) mouse parabiotic surgery, in order to see how immunocompetent WT mice naturally respond to HBV, and how tolerant HBs-Tg mice influence the anti-HBV immunity from WT mice. It was found that WT CD8 T cells markedly accumulated into the liver of HBs-Tg parabionts, and importantly, almost all HBsAg-specific CD8 T cells derived from WT but not HBs-Tg mice, making a clear separation of a normal immune response from WT donor and a tolerant response by recipient host. Further, in the absence of host but not donor spleen, HBsAg-specific CD8 T cells disappeared, indicating that host spleen was the indispensable site for donor HBsAg-specific CD8 T cell priming though its mechanisms need further study. We found that donor CD4 T helper cells were necessary for donor HBsAg-specific CD8 T cell response by CD4-deficiency in WT or in HBs-Tg mice, indicating that an immune response was elicited between CD4 T helper cells and CD8 cytotoxic T cells of donor in the host but not donor spleen. It was noted that compared to donor CD4 T cells, host CD4 T cells were characterized with more tolerant features by harboring more CD25Foxp3 Tregs with higher expression of PD-1 and TIGIT in the spleen of HBs-Tg parabionts, which exhibited suppressive function on CD8 T cells directly. Moreover, the Th1/Treg ratio was enhanced after parabiosis, suggesting that donor T helper cells may overcome the negative regulation of host Tregs in host spleen. In conclusion, both incompetent anti-HBV CD8 T cells and insufficient help from CD4 T cells are the major mechanisms underlying immune tolerance in HBs-Tg mice which helps explain HBV persistence.

摘要

人们广泛认识到,HBV 转基因(Tg)小鼠存在中枢耐受,但在使用强效佐剂增强后,成年 HBs-Tg 小鼠对 HBV 疫苗可能会产生免疫反应,这留下了一个谜团,有待探索其免疫耐受机制。在这里,通过将 WT(供体)和 HBs-Tg(宿主)小鼠联体手术,生成了 WT-HBs-Tg 联体小鼠模型,以观察免疫功能正常的 WT 小鼠如何自然地对 HBV 产生反应,以及 HBs-Tg 小鼠的免疫耐受如何影响来自 WT 小鼠的抗 HBV 免疫。结果发现,WT CD8 T 细胞明显聚集到 HBs-Tg 联体小鼠的肝脏中,重要的是,几乎所有 HBsAg 特异性 CD8 T 细胞都来自 WT 而不是 HBs-Tg 小鼠,从而清楚地区分了来自 WT 供体的正常免疫反应和受体宿主的耐受反应。此外,在没有宿主但有供体脾脏的情况下,HBsAg 特异性 CD8 T 细胞消失,表明宿主脾脏是供体 HBsAg 特异性 CD8 T 细胞启动的不可或缺部位,但其机制仍需进一步研究。我们发现,通过在 WT 或 HBs-Tg 小鼠中缺乏 CD4 缺陷,供体 CD4 T 辅助细胞是供体 HBsAg 特异性 CD8 T 细胞反应所必需的,这表明在宿主中,而不是在供体脾脏中,供体 CD4 T 辅助细胞与 CD8 细胞毒性 T 细胞之间引发了免疫反应。值得注意的是,与供体 CD4 T 细胞相比,宿主 CD4 T 细胞在 HBs-Tg 联体小鼠的脾脏中具有更多的耐受特征,表现为更多表达 PD-1 和 TIGIT 的 CD25Foxp3 Treg,并具有直接抑制 CD8 T 细胞的功能。此外,联体后 Th1/Treg 比值增强,表明供体辅助性 T 细胞可能克服了宿主脾脏中宿主 Treg 的负调节。总之,无能的抗 HBV CD8 T 细胞和来自 CD4 T 细胞的不足帮助解释了 HBs-Tg 小鼠的免疫耐受机制,有助于解释 HBV 的持续存在。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/fabec6ff80fd/fimmu-13-993246-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/eab9cbec1485/fimmu-13-993246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/479277c6c1b6/fimmu-13-993246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/8d77f712a57a/fimmu-13-993246-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/30ce687ee378/fimmu-13-993246-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/462ada9fac4c/fimmu-13-993246-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/56173f33197a/fimmu-13-993246-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/0657919e8939/fimmu-13-993246-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/b5f5079d2746/fimmu-13-993246-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/b914fcc6aab3/fimmu-13-993246-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/fabec6ff80fd/fimmu-13-993246-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/eab9cbec1485/fimmu-13-993246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/479277c6c1b6/fimmu-13-993246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/8d77f712a57a/fimmu-13-993246-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/30ce687ee378/fimmu-13-993246-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/462ada9fac4c/fimmu-13-993246-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/56173f33197a/fimmu-13-993246-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/0657919e8939/fimmu-13-993246-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/b5f5079d2746/fimmu-13-993246-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/b914fcc6aab3/fimmu-13-993246-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/9530942/fabec6ff80fd/fimmu-13-993246-g010.jpg

相似文献

1
HBV immune tolerance of HBs-transgenic mice observed through parabiosis with WT mice.通过与野生型小鼠联体观察 HBs 转基因小鼠的 HBV 免疫耐受。
Front Immunol. 2022 Sep 20;13:993246. doi: 10.3389/fimmu.2022.993246. eCollection 2022.
2
Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models.在初次免疫期间激活 CD4 T 细胞决定了治疗性乙型肝炎疫苗在乙肝携带者小鼠模型中的成功。
J Hepatol. 2023 Apr;78(4):717-730. doi: 10.1016/j.jhep.2022.12.013. Epub 2023 Jan 9.
3
Immunizations with hepatitis B viral antigens and a TLR7/8 agonist adjuvant induce antigen-specific immune responses in HBV-transgenic mice.用乙型肝炎病毒抗原和一种TLR7/8激动剂佐剂进行免疫接种可在乙肝病毒转基因小鼠中诱导抗原特异性免疫反应。
Int J Infect Dis. 2014 Dec;29:31-6. doi: 10.1016/j.ijid.2014.07.015. Epub 2014 Oct 23.
4
Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells.克服乙型肝炎病毒转基因小鼠的耐受性:调节性T细胞可能发挥的作用。
Microbiol Immunol. 2003;47(6):453-60. doi: 10.1111/j.1348-0421.2003.tb03370.x.
5
Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen.对乙肝表面抗原持续存在的小鼠T1或T2免疫反应被排除在表达转基因编码乙肝表面抗原的肝脏之外。
J Immunol. 2000 Apr 15;164(8):4235-43. doi: 10.4049/jimmunol.164.8.4235.
6
IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.IL-12 为基础的疫苗治疗可逆转乙型肝炎病毒携带者小鼠模型中的肝诱导的全身耐受。
J Immunol. 2013 Oct 15;191(8):4184-93. doi: 10.4049/jimmunol.1203449. Epub 2013 Sep 18.
7
Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.乙型肝炎表面抗原(HBsAg)和核心抗原(HBcAg)联合CpG寡脱氧核苷酸作为慢性乙型肝炎感染的新型治疗性疫苗。
Vaccine. 2015 Aug 20;33(35):4247-54. doi: 10.1016/j.vaccine.2015.03.079. Epub 2015 Apr 6.
8
Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants.通过接种交叉反应性天然乙肝表面抗原(HBsAg)变体疫苗打破乙肝表面抗原(HBsAg)转基因小鼠的耐受性。
Eur J Immunol. 2003 Dec;33(12):3342-52. doi: 10.1002/eji.200324403.
9
Induction and maintenance of anti-HBs in immunosuppressed murine hepatitis B virus carriers by a novel vaccination approach: implications for use in hepatitis B virus-infected subjects with liver transplantation.通过一种新型疫苗接种方法在免疫抑制的小鼠乙型肝炎病毒携带者中诱导和维持抗-HBs:对乙型肝炎病毒感染的肝移植受者的应用意义
J Gastroenterol. 2004 Sep;39(9):851-8. doi: 10.1007/s00535-004-1401-2.
10
Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.一种基于树突状细胞的治疗性疫苗对小鼠慢性乙型肝炎病毒携带者的制备及疗效
Int J Mol Med. 2004 Aug;14(2):295-9.

引用本文的文献

1
T cell characteristics in individuals with different immune responses after hepatitis B vaccination.乙肝疫苗接种后不同免疫反应个体的T细胞特征
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Dec 28;49(12):1983-1990. doi: 10.11817/j.issn.1672-7347.2024.240172.
2
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx.小鼠中与乙肝病毒相关的肝癌发展依赖于信号转导及转录激活因子3(STAT3),并表明乙肝病毒X蛋白(HBx)具有致癌作用。
JHEP Rep. 2024 Jun 6;6(10):101128. doi: 10.1016/j.jhepr.2024.101128. eCollection 2024 Oct.
3
A hepatitis B virus-derived peptide combined with HBsAg exerts an anti-HBV effect in an HBV transgenic mouse model as a therapeutic vaccine.

本文引用的文献

1
PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection.PD-L1-PD-1 相互作用在稳态和感染期间限制效应调节性 T 细胞群体。
Nat Immunol. 2022 May;23(5):743-756. doi: 10.1038/s41590-022-01170-w. Epub 2022 Apr 18.
2
NK cells limit therapeutic vaccine-induced CD8T cell immunity in a PD-L1-dependent manner.自然杀伤细胞以 PD-L1 依赖的方式限制治疗性疫苗诱导的 CD8T 细胞免疫。
Sci Transl Med. 2022 Apr 13;14(640):eabi4670. doi: 10.1126/scitranslmed.abi4670.
3
Innate and adaptive immune escape mechanisms of hepatitis B virus.
乙肝病毒衍生肽与 HBsAg 联合作为治疗性疫苗在乙肝转基因小鼠模型中发挥抗 HBV 作用。
Front Immunol. 2023 Jun 2;14:1155637. doi: 10.3389/fimmu.2023.1155637. eCollection 2023.
4
Studying T Cell Responses to Hepatotropic Viruses in the Liver Microenvironment.研究肝脏微环境中T细胞对嗜肝病毒的反应。
Vaccines (Basel). 2023 Mar 17;11(3):681. doi: 10.3390/vaccines11030681.
乙型肝炎病毒的先天和适应性免疫逃逸机制。
World J Gastroenterol. 2022 Mar 7;28(9):881-896. doi: 10.3748/wjg.v28.i9.881.
4
Monocytic MDSCs homing to thymus contribute to age-related CD8+ T cell tolerance of HBV.单核细胞来源的髓系抑制细胞归巢至胸腺有助于年龄相关的乙型肝炎病毒 CD8+T 细胞耐受。
J Exp Med. 2022 Apr 4;219(4). doi: 10.1084/jem.20211838. Epub 2022 Mar 7.
5
HBV-Specific CD8+ T-Cell Tolerance in the Liver.HBV 特异性 CD8+ T 细胞在肝脏中的耐受。
Front Immunol. 2021 Aug 6;12:721975. doi: 10.3389/fimmu.2021.721975. eCollection 2021.
6
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma.非终末耗竭的肿瘤驻留记忆 HBV 特异性 T 细胞反应与肝细胞癌无复发生存相关。
Immunity. 2021 Aug 10;54(8):1825-1840.e7. doi: 10.1016/j.immuni.2021.06.013. Epub 2021 Jul 15.
7
CD4 T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy.慢性乙型肝炎中的 CD4 T 细胞和 T 细胞靶向免疫治疗。
Cells. 2021 May 6;10(5):1114. doi: 10.3390/cells10051114.
8
Immunobiology and pathogenesis of hepatitis B virus infection.乙型肝炎病毒感染的免疫生物学与发病机制
Nat Rev Immunol. 2022 Jan;22(1):19-32. doi: 10.1038/s41577-021-00549-4. Epub 2021 May 17.
9
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance.PD-1 抑制调节性 T 细胞的抑制活性对于免疫耐受至关重要。
J Exp Med. 2021 Jan 4;218(1). doi: 10.1084/jem.20182232.
10
Modulation of regulatory T cell function and stability by co-inhibitory receptors.共抑制受体对调节性 T 细胞功能和稳定性的调节。
Nat Rev Immunol. 2020 Nov;20(11):680-693. doi: 10.1038/s41577-020-0296-3. Epub 2020 Apr 8.